"At our Rockville Centre, NY location, OCLI provides a full range of eye care services to our patients. Here, you can have an eye examination, your cataract surgery, your LASIK consultation, and much more. With so many talented and skilled eye doctors, you are sure to find an ophthalmologist who fits your individual needs. If you are interested in booking an eye care appointment at our Rockville Centre location, be sure to give us a call or request an appointment online!"

During the past decade, Ophthalmic Consultants of Long Island conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 7 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ophthalmic Consultants of Long Island" #1 sponsor was "Bausch & Lomb Incorporated" with 3 trials, followed by "Genentech, Inc." with 3 trials sponsored, "Glaukos Corporation" with 3 trials sponsored, "Abbott Medical Optics" with 2 trials sponsored and "Hoffmann-La Roche" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 14 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ophthalmic Consultants of Long Island" #1 collaborator was "Allergan" with 1 trials as a collaborator, "Novartis" with 1 trials as a collaborator and "Pfizer" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ophthalmic Consultants of Long Island" are "Cataract" (4 trials), "Dry Eye Disease" (3 trials), "Cataract Extraction" (2 trials), "Geographic Atrophy" (2 trials) and "Keratoconjunctivitis Sicca" (2 trials). Many other conditions were trialed in "Ophthalmic Consultants of Long Island" in a lesser frequency.

Most popular intervention types in "Ophthalmic Consultants of Long Island" are "Drug" (21 trials), "Device" (5 trials), "Other" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Galegenimab" (2 trials), "LX201" (2 trials), "UVA Irradiation" (2 trials) and "riboflavin ophthalmic solution" (2 trials). Other intervention names were less common.

The vast majority of trials in "Ophthalmic Consultants of Long Island" are 25 trials for "All" genders.

Currently, there are NaN active trials in "Ophthalmic Consultants of Long Island". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Ophthalmic Consultants of Long Island, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in Ophthalmic Consultants of Long Island, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 5 trials, and there were also 1 trials that are defined as “Not Applicable".